These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2682323)

  • 1. Potential roles of protease inhibitors in Alzheimer's disease.
    Abraham CR
    Neurobiol Aging; 1989; 10(5):463-5; discussion 477-8. PubMed ID: 2682323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zeroing in on amyloid proteins in Alzheimer disease therapy.
    Festoff BW
    Neurobiol Aging; 1989; 10(5):465-6; discussion 477-8. PubMed ID: 2510039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel therapy for Alzheimer's disease.
    DeFeudis FV
    Neurobiol Aging; 1989; 10(5):467-8; discussion 477-8. PubMed ID: 2510040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid forming proteases: therapeutic targets for Alzheimer's disease.
    Schimmöller F; Higaki JN; Cordell B
    Curr Pharm Des; 2002; 8(28):2521-31. PubMed ID: 12369937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ca(2+)-dependent 68-kilodalton protease in familial Alzheimer's disease cells cleaves the N-terminus of beta-amyloid.
    Matsumoto A; Fujiwara Y
    Biochemistry; 1994 Apr; 33(13):3941-8. PubMed ID: 8142398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serine proteases, their inhibitors and allergy.
    Smith PK; Harper JI
    Allergy; 2006 Dec; 61(12):1441-7. PubMed ID: 17073875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A calcium-activated protease from Alzheimer's disease brain cleaves at the N-terminus of the amyloid beta-protein.
    Abraham CR; Driscoll J; Potter H; Van Nostrand WE; Tempst P
    Biochem Biophys Res Commun; 1991 Jan; 174(2):790-6. PubMed ID: 1993072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The involvement of astrocytes and an acute phase response in the amyloid deposition of Alzheimer's disease.
    Potter H
    Prog Brain Res; 1992; 94():447-58. PubMed ID: 1287729
    [No Abstract]   [Full Text] [Related]  

  • 9. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE.
    Vassar R; Bennett BD; Babu-Khan S; Kahn S; Mendiaz EA; Denis P; Teplow DB; Ross S; Amarante P; Loeloff R; Luo Y; Fisher S; Fuller J; Edenson S; Lile J; Jarosinski MA; Biere AL; Curran E; Burgess T; Louis JC; Collins F; Treanor J; Rogers G; Citron M
    Science; 1999 Oct; 286(5440):735-41. PubMed ID: 10531052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine proteases and their serpin inhibitors in Alzheimer's disease.
    Ho GJ; Smirnova IV; Akaaboune M; Hantaï D; Festoff BW
    Biomed Pharmacother; 1994; 48(7):296-304. PubMed ID: 7858160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysteine protease inhibitors reduce brain beta-amyloid and beta-secretase activity in vivo and are potential Alzheimer's disease therapeutics.
    Hook G; Hook VY; Kindy M
    Biol Chem; 2007 Sep; 388(9):979-83. PubMed ID: 17696783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of beta-amyloid in the development of Alzheimer's disease.
    Ii K
    Drugs Aging; 1995 Aug; 7(2):97-109. PubMed ID: 7579788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A serine protease in Alzheimer's disease cells cleaves a 16K-peptide with flanking residues upstream to beta-amyloid-N-terminus as natural substrate.
    Matsumoto A; Matsumoto R; Baba H; Fujiwara Y
    Neurosci Lett; 1995 Aug; 195(3):171-4. PubMed ID: 8584202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel prolyl endopeptidase inhibitor, JTP-4819--its behavioral and neurochemical properties for the treatment of Alzheimer's disease.
    Toide K; Shinoda M; Miyazaki A
    Rev Neurosci; 1998; 9(1):17-29. PubMed ID: 9683325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APP processing and the APP-KPI domain involvement in the amyloid cascade.
    Menéndez-González M; Pérez-Pinera P; Martínez-Rivera M; Calatayud MT; Blázquez Menes B
    Neurodegener Dis; 2005; 2(6):277-83. PubMed ID: 16909010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation.
    Gervais FG; Xu D; Robertson GS; Vaillancourt JP; Zhu Y; Huang J; LeBlanc A; Smith D; Rigby M; Shearman MS; Clarke EE; Zheng H; Van Der Ploeg LH; Ruffolo SC; Thornberry NA; Xanthoudakis S; Zamboni RJ; Roy S; Nicholson DW
    Cell; 1999 Apr; 97(3):395-406. PubMed ID: 10319819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of serine protease activity by aluminum: implications for Alzheimer disease.
    Clauberg M; Joshi JG
    Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1009-12. PubMed ID: 7679214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-Amyloid vasoactivity in Alzheimer's disease.
    Gurwitz D
    Lancet; 1996 May; 347(9013):1492. PubMed ID: 8676666
    [No Abstract]   [Full Text] [Related]  

  • 19. [Molecular cytogenetic study and chromosome abnormalities in Alzheimer's disease. Protease-inhibitory peptides and amyloid beta protein in Alzheimer's disease].
    Ito H; Kitaguchi N
    Nihon Rinsho; 1988 Jul; 46(7):1514-20. PubMed ID: 3065525
    [No Abstract]   [Full Text] [Related]  

  • 20. Enzymes point way to potential Alzheimer's therapies.
    Pennisi E
    Science; 1999 Oct; 286(5440):650-1. PubMed ID: 10577210
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.